Conmed Corp (CNMD) Misses Q2 EPS by 1c; Guides
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $35.95 +4.02%
EPS Growth %: -3.5%
Financial Fact:
Net Income Basic: 0.26
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: -3.5%
Financial Fact:
Net Income Basic: 0.26
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Conmed Corp (NASDAQ: CNMD) reported Q2 EPS of $0.43, $0.01 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $193 million versus the consensus estimate of $193.55 million.
Conmed Corp sees FY2013 EPS of $1.80-$1.85, versus prior guidance of $1.80-$1.90 and the consensus of $1.86. Conmed Corp sees FY2013 revenue of $770-775 million, versus prior guidance of $770-780 million.
Conmed Corp sees Q2 2013 EPS of $0.37-$0.42, versus the consensus of $0.42. Conmed Corp sees Q2 2013 revenue of $184-189 million, versus the consensus of $186.3 million.
For earnings history and earnings-related data on Conmed Corp (CNMD) click here.
Conmed Corp sees FY2013 EPS of $1.80-$1.85, versus prior guidance of $1.80-$1.90 and the consensus of $1.86. Conmed Corp sees FY2013 revenue of $770-775 million, versus prior guidance of $770-780 million.
Conmed Corp sees Q2 2013 EPS of $0.37-$0.42, versus the consensus of $0.42. Conmed Corp sees Q2 2013 revenue of $184-189 million, versus the consensus of $186.3 million.
For earnings history and earnings-related data on Conmed Corp (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- McCormick & Co. (MKC) Tops Q2 EPS by 10c ; Offers Guidance
- Benchmark Reiterates Buy Rating on IMAX Corporation (IMAX), Highlights 'The Odyssey' Potential
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
